Harding Loevner LP Repligen Corp Transaction History
Harding Loevner LP
- $14.4 Billion
- Q4 2024
A detailed history of Harding Loevner LP transactions in Repligen Corp stock. As of the latest transaction made, Harding Loevner LP holds 340,083 shares of RGEN stock, worth $54.1 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
340,083
Previous 916,142
62.88%
Holding current value
$54.1 Million
Previous $136 Million
64.1%
% of portfolio
0.34%
Previous 0.8%
Shares
11 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.2 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.13 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$811 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$269 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$245 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.82B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....